A phase I/II study of the safety and efficacy of brostallicin (PNU-166196A) in adult patients with multiple myeloma that has progressed on prior chemotherapy
Phase of Trial: Phase I/II
Latest Information Update: 15 Jan 2014
At a glance
- Drugs Brostallicin (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 10 Feb 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 29 Sep 2005 New trial record.